Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-01-31 · accession 0000899243-23-010137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +56.2K | 1.12M | +5% | $0 |
| D | 2023-03-31 | 2023-03-06 | BEAM | Evans John M. | CEO, Dir | L - Small Acq | $0.00 | +225 | 1.06M | +0.0% | $0 |
| D | 2023-03-31 | 2023-03-31 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $7.22 | +13.8K | 1.13M | +1% | +$100.0K |
| D | 2023-03-31 | 2023-01-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +112.5K | 112.5K | New | $0 |
| D | 2023-03-31 | 2023-03-31 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.00 | -13.8K | 196.9K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | A | A | 56,250 | $0.00 | 1,115,303 | D | — | — | (F3) Represents restricted stock units ("RSUs") granted to the Reporting Person under BEAM's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date. |
| 2 | Common | Common Stock | 2023-03-06 | L | A | 225 | $0.00 | 1,059,053 | D | — | — | (F2) Includes 308 shares and acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2022. |
| 3 | Common | Common Stock | 2023-03-31 | M | A | 13,850 | $7.22 | 1,129,153 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-01-31 | A | A | 112,500 | $0.00 | 112,500 | D | $43.45 · — to 2033-01-31 | 112,500 Common Stock | (F4) This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with BEAM through each vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-03-31 | M | D | 13,850 | $0.00 | 196,904 | D | $7.22 · — to 2029-05-17 | 13,850 Common Stock | (F5) This stock option vests as to 25% on the first anniversary of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested. . |